Creative Medical Technology Holdings Announces Reversion of Liver Failure Using ImmCelz® Personalized Cellular Immunotherapy in Preclinical Model ...Middle East

PHOENIX, Dec. 29, 2020 /PRNewswire/ -- (OTC-CELZ) Creative Medical Technology Holdings Inc. announced today novel data and patent filing No. 63131261 describing the ability of ImmCelz® to reverse liver failure in the carbon tetrachloride preclinical model of hepatocyte necrosis. These...

Read More Details
Finally We wish PressBee provided you with enough information of ( Creative Medical Technology Holdings Announces Reversion of Liver Failure Using ImmCelz® Personalized Cellular Immunotherapy in Preclinical Model )

Also on site :

• ‘This is murder': Family remembers victims killed in Austin fire as 4th body recovered
• SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, NVEE, SOAR, PLL on Behalf of Shareholders
• Ilona Maher Gets Invite to Dance With Coco Gauff and Aryna Sabalenka